Jitendra Ganju

544 total citations
30 papers, 349 citations indexed

About

Jitendra Ganju is a scholar working on Statistics and Probability, Management Science and Operations Research and Statistics, Probability and Uncertainty. According to data from OpenAlex, Jitendra Ganju has authored 30 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Statistics and Probability, 6 papers in Management Science and Operations Research and 6 papers in Statistics, Probability and Uncertainty. Recurrent topics in Jitendra Ganju's work include Statistical Methods in Clinical Trials (21 papers), Statistical Methods and Inference (7 papers) and Statistical Methods and Bayesian Inference (6 papers). Jitendra Ganju is often cited by papers focused on Statistical Methods in Clinical Trials (21 papers), Statistical Methods and Inference (7 papers) and Statistical Methods and Bayesian Inference (6 papers). Jitendra Ganju collaborates with scholars based in United States, Italy and Poland. Jitendra Ganju's co-authors include James M. Lucas, Rino Rappuoli, Mario Contorni, Bruce F. Scharschmidt, Giuseppe Del Giudice, Bernd Rosenkranz, Emanuela Palla, Viola Schultze, Samuele Peppoloni and Deborah L. Novicki and has published in prestigious journals such as Circulation, Gastroenterology and Biometrics.

In The Last Decade

Jitendra Ganju

28 papers receiving 332 citations

Peers

Countries citing papers authored by Jitendra Ganju

Since Specialization

Citations

This map shows the geographic impact of Jitendra Ganju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitendra Ganju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitendra Ganju more than expected).

Fields of papers citing papers by Jitendra Ganju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jitendra Ganju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitendra Ganju. The network helps show where Jitendra Ganju may publish in the future.

Co-authorship network of co-authors of Jitendra Ganju

This figure shows the co-authorship network connecting the top 25 collaborators of Jitendra Ganju. A scholar is included among the top collaborators of Jitendra Ganju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jitendra Ganju. Jitendra Ganju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges and strategies for clinical trials in propionic and methylmalonic acidemias 2023 ·Molecular Genetics and Metabolism ·Jerry Vockley, Barbara K. Burton, Agnieszka Jurecka, Jitendra Ganju, (unknown), Roberto T. Zori, Nicola Longo	3
2	Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegeneration 2023 ·Frontiers in Neurology ·Aleksandar Videnović, Helle Cecilie Viekilde Pfeiffer, Anna Tylki‐Szymańska, Elizabeth Berry‐Kravis, Fatih Süheyl Ezgü, Jitendra Ganju, (unknown), Anthony E. Lang	2
3	Sample size formula for a win ratio endpoint 2022 ·Statistics in Medicine ·Ron Yu, Jitendra Ganju	11
4	Improving the Standards of Reporting of Clinical Trial Data 2020 ·Therapeutic Innovation & Regulatory Science ·Jitendra Ganju	0
5	Abstract 14214: ATTRibute-CM: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Phase 3 Study of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) 2019 ·Circulation ·Julian D. Gillmore, Pablo García‐Pavía, Martha Grogan, Mazen Hanna, Stephen B. Heitner, Daniel Jacoby, Mathew S. Maurer, Claudio Rapezzi, Sanjiv J. Shah, Jitendra Ganju, Leonid Katz, Jonathan C. Fox, Daniel P. Judge	5
6	Robust inference for group sequential trials 2017 ·Pharmaceutical Statistics ·Jitendra Ganju, Yunzhi Lin, Kefei Zhou	0
7	Improving the operational efficiency of Phase 2 and 3 trials 2016 ·Trials ·Jitendra Ganju	2
8	Variation in Liver Biochemistries in Patients with Decompensated Cirrhosis: Implications for Assessing Drug-Induced Liver Injury in Clinical Trials 2016 ·Pharmaceutical Medicine ·Marzena Jurek, Masoud Mokhtarani, John M. Vierling, Dion F. Coakley, Jitendra Ganju, Richard Rowell, Bruce F. Scharschmidt	2
9	A single test for rejecting the null hypothesis in subgroups and in the overall sample 2016 ·Journal of Biopharmaceutical Statistics ·Yunzhi Lin, Kefei Zhou, Jitendra Ganju	2
10	The potential for increased power from combining P-values testing the same hypothesis 2014 ·Statistical Methods in Medical Research ·Jitendra Ganju, Guo‐guang Ma	8
11	Comments on ‘Sample size for equivalence trials: a case study from a vaccine lot consistency trial’ 2012 ·Statistics in Medicine ·Jitendra Ganju, Allen Izu	1
12	Re‐estimating the sample size of an on‐going blinded trial based on the method of randomization block sums 2008 ·Statistics in Medicine ·Jitendra Ganju, (unknown)	9
13	Sample size for equivalence trials: A case study from a vaccine lot consistency trial 2008 ·Statistics in Medicine ·Jitendra Ganju, Allen Izu, Alessandra Anemona	3
14	Safety and Immunogenicity of an Intramuscular Helicobacter pylori Vaccine in Noninfected Volunteers: A Phase I Study 2008 ·Gastroenterology ·Peter Malfertheiner, Viola Schultze, Bernd Rosenkranz, Stefan H. E. Kaufmann, Timo Ulrichs, Deborah L. Novicki, Francesco Norelli, Mario Contorni, Samuele Peppoloni, (unknown), (unknown), Jitendra Ganju, Emanuela Palla, Rino Rappuoli, Bruce F. Scharschmidt, Giuseppe Del Giudice	137
15	Some Unexamined Aspects of Analysis of Covariance in Pretest–Posttest Studies 2004 ·Biometrics ·Jitendra Ganju	8
16	Stratified experiments reexamined with emphasis on multicenter trials 2003 ·Controlled Clinical Trials ·Jitendra Ganju, Devan V. Mehrotra	11
17	Analysis of Unbalanced Data from an Experiment with Random Block Effects and Unequally Spaced Factor Levels 2000 ·The American Statistician ·Jitendra Ganju, James M. Lucas	10
18	A SIMPLE WAY TO ESTIMATE THE MEDIAN TIME AND COMPARE SURVIVAL DISTRIBUTIONS IN ANALGESIC TRIALS UNDER INFORMATIVE CENSORING 1999 ·Journal of Biopharmaceutical Statistics ·Jitendra Ganju, Edward Lakatos, (unknown)	1
19	Bias in test statistics when restrictions in randomization are caused by factors 1997 ·Communication in Statistics- Theory and Methods ·Jitendra Ganju, James M. Lucas	27
20	Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee 1995 ·Clinical Therapeutics ·(unknown), Bernard Rubin, (unknown), F. Gilbert McMahon, David Lee, (unknown), (unknown), Marshall Sack, David Sikes, Robert G. Trapp, (unknown), Michael E. Kuss, Jitendra Ganju, Tomás S. Bocanegra	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact